ORG-201745
ORG-201745 is a progestin which was originated by Organon and was under development by Schering-Plough (which acquired Organon in 2007) for the treatment of "female genital diseases" and as a hormonal contraceptive for the prevention of pregnancy but was never marketed.[1]
| Clinical data | |
|---|---|
| Drug class | Progestin; Progestogen |
| Identifiers | |
| CAS Number | |
References
- "ORG 201745 - AdisInsight". adisinsight.springer.com.
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.